EW Operating Cash Flow (Statement)

Edwards Lifesciences · Operating Cash Flow (Statement)

EW logo

EW Operating Cash Flow (Statement)

Latest reported$1.72B
EW TTM Cash from Operations ($137.00M → $1.72B)
High-resolution chart · PNG

EW operating cash flow (statement) history

Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.

Edwards Lifesciences Operating Cash Flow (Statement) — Trailing twelve months (TTM) (USD)
Period endingOperating Cash Flow (Statement) (USD)
1,720,300,000
1,358,600,000
1,595,200,000
1,016,800,000
794,900,000
876,200,000
542,300,000
806,400,000
866,100,000
528,200,000
895,800,000
1,042,000,000
940,400,000
1,239,000,000
1,218,200,000
1,309,000,000
1,531,000,000
1,724,900,000
1,732,100,000
1,758,500,000
1,442,700,000
1,147,800,000
1,054,300,000
1,053,700,000
1,274,900,000
1,384,900,000
1,179,400,000
1,073,000,000
978,000,000
777,000,000
926,800,000
997,700,000
966,200,000
1,023,700,000
1,000,700,000
837,900,000
733,000,000
725,600,000
704,400,000
607,100,000
603,700,000
583,500,000
549,700,000
539,100,000
348,800,000
956,700,000
1,022,300,000
1,040,400,000
1,175,300,000
524,300,000
472,700,000
487,800,000
472,000,000
491,800,000
373,800,000
390,500,000
356,400,000
268,900,000
314,500,000
265,400,000
264,600,000
253,300,000
251,400,000
223,300,000
198,400,000
214,300,000
165,300,000
179,900,000
122,200,000
87,300,000
153,200,000
149,600,000
195,200,000
204,000,000
210,200,000
203,300,000
204,100,000
205,900,000
230,800,000
205,100,000
183,900,000
176,900,000
136,800,000
143,400,000
169,300,000
165,400,000
180,600,000
198,100,000
159,600,000
167,000,000
122,300,000
101,100,000
105,400,000
112,900,000
120,600,000
119,900,000
117,700,000
107,400,000
101,000,000
104,000,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.